Medicine & Life Sciences
Squamous Cell Carcinoma of Head and Neck
100%
Cetuximab
63%
Head and Neck Neoplasms
53%
Survival
37%
Squamous Cell Carcinoma
35%
Peripheral Blood Stem Cells
32%
Stem Cell Transplantation
31%
Transplants
31%
Neoplasms
30%
Bone Marrow Transplantation
27%
130-nm albumin-bound paclitaxel
26%
Granulocyte Colony-Stimulating Factor
26%
Drug Therapy
26%
Sarcoma
25%
Graft vs Host Disease
25%
Therapeutics
24%
Radiotherapy
24%
Peripheral Blood Stem Cell Transplantation
23%
Cisplatin
23%
Autologous Transplantation
23%
Induction Chemotherapy
22%
Oropharyngeal Neoplasms
22%
Progression-Free Survival
21%
Whole-Body Irradiation
21%
palbociclib
20%
Bone Marrow
19%
Recurrence
18%
Unrelated Donors
18%
Docetaxel
18%
Tissue Donors
18%
pembrolizumab
17%
Stem Cells
17%
Homologous Transplantation
17%
Radiation
16%
Neutrophils
16%
Transplant Recipients
16%
Granulocytes
15%
Neck
14%
Cyclophosphamide
13%
Neoplasm Metastasis
13%
Safety
13%
dusquetide
12%
Breast Neoplasms
12%
Bone Neoplasms
12%
Albumin-Bound Paclitaxel
12%
Platinum
11%
temsirolimus
11%
Allogeneic Cells
11%
Mouth
10%
Leukemia, Myelogenous, Chronic, BCR-ABL Positive
10%